Researchers evaluate the health-related outcomes of nature-based interventions in children with autism.
JAK1 inhibition and Anti-PD1 therapy enhance outcomes in advanced lung cancer
Adding an anti-inflammatory drug to anti-PD1 checkpoint inhibitor immunotherapy has shown great promise as a new strategy against advanced lung cancer, based on results from